ARCHIVES

US Oncology Begins Trial Of Taxotere And Xeloda

This article is from The Cancer Letter archive.

Vol. 25 No. 9 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: ACS Board Names McGinnis Prsident; Fuller Re-Elected chairman; Lenhard Is Vice President

November 25, 1994

SAIC Frederick Offers Use Of Drug Facility

August 4, 1995

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

NCI Plans Progress Review In Lymphoma This Year.

March 10, 2000

Report Redefines Cancer Control Research, Sets the Agenda For Newest NCI Division

October 17, 1997

In Congress: Senate, House Reports List Priorities For NCI

August 8, 1997